Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Future prospects and challenges of vaccines against filariasis

Identifieur interne : 004782 ( Main/Exploration ); précédent : 004781; suivant : 004783

Future prospects and challenges of vaccines against filariasis

Auteurs : S. A. Babayan [Royaume-Uni] ; J. E. Allen [Royaume-Uni] ; D. W. Taylor [Royaume-Uni]

Source :

RBID : ISTEX:7411258933FABD666D7BBA415B354AD375A08EC6

Abstract

Filarial infections remain a major public health and socio‐economic problem across the tropics, despite considerable effort to reduce disease burden or regionally eliminate the infection with mass drug administration programmes. The sustainability of these programmes is now open to question owing to a range of issues, not least of which is emerging evidence for drug resistance. Vaccination, if developed appropriately, remains the most cost‐effective means of long‐term disease control. The rationale for the feasibility of vaccination against filarial parasites including onchocerciasis (river blindness, Onchocerca volvulus) and lymphatic filariasis (Wuchereria bancrofti or Brugia malayi) is founded on evidence from both humans and animal models for the development of protective immunity. Nonetheless, enormous challenges need to be faced in terms of overcoming parasite‐induced suppression without inducing pathology as well as the need to both recognize and tackle evolutionary and ecological obstacles to successful vaccine development. Nonetheless, new technological advances in addition to systems biology approaches offer hope that optimal immune responses can be induced that will prevent infection, disease and/or transmission.

Url:
DOI: 10.1111/j.1365-3024.2011.01350.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Future prospects and challenges of vaccines against filariasis</title>
<author>
<name sortKey="Babayan, S A" sort="Babayan, S A" uniqKey="Babayan S" first="S. A." last="Babayan">S. A. Babayan</name>
</author>
<author>
<name sortKey="Allen, J E" sort="Allen, J E" uniqKey="Allen J" first="J. E." last="Allen">J. E. Allen</name>
</author>
<author>
<name sortKey="Taylor, D W" sort="Taylor, D W" uniqKey="Taylor D" first="D. W." last="Taylor">D. W. Taylor</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7411258933FABD666D7BBA415B354AD375A08EC6</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1111/j.1365-3024.2011.01350.x</idno>
<idno type="url">https://api.istex.fr/document/7411258933FABD666D7BBA415B354AD375A08EC6/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003633</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003633</idno>
<idno type="wicri:Area/Istex/Curation">003633</idno>
<idno type="wicri:Area/Istex/Checkpoint">000479</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000479</idno>
<idno type="wicri:doubleKey">0141-9838:2012:Babayan S:future:prospects:and</idno>
<idno type="wicri:Area/Main/Merge">004807</idno>
<idno type="wicri:Area/Main/Curation">004782</idno>
<idno type="wicri:Area/Main/Exploration">004782</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Future prospects and challenges of vaccines against filariasis</title>
<author>
<name sortKey="Babayan, S A" sort="Babayan, S A" uniqKey="Babayan S" first="S. A." last="Babayan">S. A. Babayan</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute of Immunology and Infection Research, and Centre for Immunity, Infection & Evolution, University of Edinburgh, Edinburgh</wicri:regionArea>
<placeName>
<settlement type="city">Édimbourg</settlement>
<region type="country">Écosse</region>
<settlement type="city">Édimbourg</settlement>
</placeName>
<orgName type="university">Université d'Édimbourg</orgName>
</affiliation>
</author>
<author>
<name sortKey="Allen, J E" sort="Allen, J E" uniqKey="Allen J" first="J. E." last="Allen">J. E. Allen</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute of Immunology and Infection Research, and Centre for Immunity, Infection & Evolution, University of Edinburgh, Edinburgh</wicri:regionArea>
<placeName>
<settlement type="city">Édimbourg</settlement>
<region type="country">Écosse</region>
<settlement type="city">Édimbourg</settlement>
</placeName>
<orgName type="university">Université d'Édimbourg</orgName>
</affiliation>
</author>
<author>
<name sortKey="Taylor, D W" sort="Taylor, D W" uniqKey="Taylor D" first="D. W." last="Taylor">D. W. Taylor</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute of Immunology and Infection Research, and Centre for Immunity, Infection & Evolution, University of Edinburgh, Edinburgh</wicri:regionArea>
<placeName>
<settlement type="city">Édimbourg</settlement>
<region type="country">Écosse</region>
<settlement type="city">Édimbourg</settlement>
</placeName>
<orgName type="university">Université d'Édimbourg</orgName>
</affiliation>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Pathway Medicine, University of Edinburgh, Edinburgh</wicri:regionArea>
<placeName>
<settlement type="city">Édimbourg</settlement>
<region type="country">Écosse</region>
<settlement type="city">Édimbourg</settlement>
</placeName>
<orgName type="university">Université d'Édimbourg</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Parasite Immunology</title>
<title level="j" type="sub">Novel Approaches to Vaccine Discovery and Parasite Control in Natural Hosts</title>
<title level="j" type="alt">PARASITE IMMUNOLOGY</title>
<idno type="ISSN">0141-9838</idno>
<idno type="eISSN">1365-3024</idno>
<imprint>
<biblScope unit="vol">34</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="243">243</biblScope>
<biblScope unit="page" to="253">253</biblScope>
<biblScope unit="page-count">11</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2012-05">2012-05</date>
</imprint>
<idno type="ISSN">0141-9838</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0141-9838</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Filarial infections remain a major public health and socio‐economic problem across the tropics, despite considerable effort to reduce disease burden or regionally eliminate the infection with mass drug administration programmes. The sustainability of these programmes is now open to question owing to a range of issues, not least of which is emerging evidence for drug resistance. Vaccination, if developed appropriately, remains the most cost‐effective means of long‐term disease control. The rationale for the feasibility of vaccination against filarial parasites including onchocerciasis (river blindness, Onchocerca volvulus) and lymphatic filariasis (Wuchereria bancrofti or Brugia malayi) is founded on evidence from both humans and animal models for the development of protective immunity. Nonetheless, enormous challenges need to be faced in terms of overcoming parasite‐induced suppression without inducing pathology as well as the need to both recognize and tackle evolutionary and ecological obstacles to successful vaccine development. Nonetheless, new technological advances in addition to systems biology approaches offer hope that optimal immune responses can be induced that will prevent infection, disease and/or transmission.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Écosse</li>
</region>
<settlement>
<li>Édimbourg</li>
</settlement>
<orgName>
<li>Université d'Édimbourg</li>
</orgName>
</list>
<tree>
<country name="Royaume-Uni">
<region name="Écosse">
<name sortKey="Babayan, S A" sort="Babayan, S A" uniqKey="Babayan S" first="S. A." last="Babayan">S. A. Babayan</name>
</region>
<name sortKey="Allen, J E" sort="Allen, J E" uniqKey="Allen J" first="J. E." last="Allen">J. E. Allen</name>
<name sortKey="Taylor, D W" sort="Taylor, D W" uniqKey="Taylor D" first="D. W." last="Taylor">D. W. Taylor</name>
<name sortKey="Taylor, D W" sort="Taylor, D W" uniqKey="Taylor D" first="D. W." last="Taylor">D. W. Taylor</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004782 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004782 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:7411258933FABD666D7BBA415B354AD375A08EC6
   |texte=   Future prospects and challenges of vaccines against filariasis
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024